Greater glucagon-like peptide-1 responses to oral glucose are associated with lower central and peripheral blood pressures
Cardiovascular diseases (CVDs) are globally the leading cause of death and hypertension is a significant risk factor. Treatment with glucagon-like peptide-1 (GLP-1) receptor agonists has been associated with d...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Julie R. Lundgren, Kristine F ærch, Daniel R. Witte, Anna E. Jonsson, Oluf Pedersen, Torben Hansen, Torsten Lauritzen, Jens J. Holst, Dorte Vistisen, Marit E. Jørgensen, Signe S. Torekov and Nanna B. Johansen Tags: Original investigation Source Type: research